PVI
DALS

Pura Vida Investments’s DA32 Life Science Tech Acquisition Corp. Class A Common Stock DALS Stock Holding History

Pura Vida Investments’s Portfolio DALS Stock Details DALS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-164,834
Closed -$1.6M – 291
2022
Q1 		$1.6M Hold
164,834
– – 0.05% 170
2021
Q4 		$1.62M Sell
164,834
-35,166
-18% -$345K 0.06% 155
2021
Q3 		$1.97M Buy
+200,000
New +$1.98M 0.06% 189

Other funds holding DALS

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
SCM
Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return
MCM
Moore Capital Management New York $4.92B AUM 35.41% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Pura Vida Investments's DALS Position: Q2 2022 in Review

Pura Vida Investments sold out of DA32 Life Science Tech Acquisition Corp. Class A Common Stock (DALS) in Q2 2022, closing a stake of 164,834 shares — an estimated $1.6M sold.

Pura Vida Investments first reported a position in DALS in Q3 2021 and held it in 3 quarters. The position peaked at $1.97M in Q3 2021. 45 funds tracked by Wall St. Rank hold DALS as of Q2 2022.

  • Pura Vida Investments reported no remaining DA32 Life Science Tech Acquisition Corp. Class A Common Stock position as of Q2 2022 after selling out during the quarter.
  • Pura Vida Investments sold 164,834 DA32 Life Science Tech Acquisition Corp. Class A Common Stock shares in Q2 2022, an estimated $1.6M.
  • Pura Vida Investments first reported a position in DA32 Life Science Tech Acquisition Corp. Class A Common Stock in Q3 2021 and held it in 3 quarters.
  • Pura Vida Investments's DA32 Life Science Tech Acquisition Corp. Class A Common Stock position peaked at $1.97M in Q3 2021.
  • 45 funds tracked by Wall St. Rank held DA32 Life Science Tech Acquisition Corp. Class A Common Stock as of Q2 2022.

Based on Pura Vida Investments's 13F filing for Q2 2022, filed 15 Aug 2022.